erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire..